| Literature DB >> 29348908 |
Zsolt Vassy1, István Kósa1,2, István Vassányi1.
Abstract
Objectives: Our goal was to apply statistical and network science techniques to depict how the clinical pathways of patients can be used to characterize the practices of care providers.Entities:
Mesh:
Year: 2017 PMID: 29348908 PMCID: PMC5734000 DOI: 10.1155/2017/6937194
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Data summary: patient numbers and 365-day relative mortality of different clinical event series types.
| Event series type | % of patients | Relative mortality |
|---|---|---|
| E | 76.11 | 0.77 |
| E-NI | 3.33 | 0.76 |
| E-NI-I | 0.70 | 0.64 |
| E-I | 4.15 | 1.62 |
| E-I-NI | 0.12 | 0.45 |
| NI | 5.00 | 2.33 |
| NI-E | 0.09 | 1.19 |
| NI-E-I | 0.02 | 0.72 |
| NI-I | 0.88 | 2.83 |
| NI-I-E | 0.11 | 0.71 |
| I | 7.80 | 8.03 |
| I-E | 1.36 | 1.64 |
| I-E-NI | 0.04 | 1.75 |
| I-NI | 0.19 | 4.56 |
| I-NI-E | 0.02 | N/A |
Reimbursement costs of events in the event series.
| Diagnostic or therapeutic event type | Associated reimbursement cost | |
|---|---|---|
| HUF | Euro | |
| Stress electrocardiography | 3408 | 13 |
| Stress echocardiography | 12,962 | 49 |
| Single photon emission computed tomography | 35,379 | 134 |
| Coronary angiography | 145,274 | 549 |
| Percutaneous coronary intervention | 804,834 | 3040 |
| Coronary artery bypass grafting | 1,262,914 | 4770 |
Figure 1Heat map of the correlation matrix of health-care centers grouped in three first level clusters. See explanation in the text.
Figure 2Position of health-care centers belonging to the three clusters. The capital (Budapest), home of about 20% of the total population, is enlarged at the top left. The blue balloon markers show the major tertiary care clinical centers with at least a total of 3000 tertiary cases in the observation period.
Upper section: distribution of event series types for each cluster and the whole population. The lower section contains outcome parameters: revascularization rate, 365-day mortality rate, and the average cost of treatment of the patients for each cluster and the whole population. Bottom line: average intracluster correlation coefficient for the cluster.
| Pathway type | Cluster 1 | Cluster 2 | Cluster 3 | Whole population |
|---|---|---|---|---|
| E (%) | 75.61 | 76.49 | 75.99 | 76.11 |
| E-NI (%) | 2.32 | 3.84 | 3.44 | 3.33 |
| E-NI-I (%) | 0.51 | 0.8 | 0.71 | 0.70 |
| E-I (%) | 5.09 | 3.39 | 4.41 | 4.15 |
| E-I-NI (%) | 0.08 | 0.12 | 0.17 | 0.12 |
| NI (%) | 3.27 | 6.55 | 4.3 | 5.00 |
| NI-E (%) | 0.02 | 0.14 | 0.08 | 0.09 |
| NI-E-I (%) | 0.01 | 0.04 | 0.02 | 0.02 |
| NI-I (%) | 0.58 | 1.15 | 0.75 | 0.88 |
| NI-I-E (%) | 0.09 | 0.12 | 0.11 | 0.11 |
| I (%) | 10.28 | 6.04 | 8.18 | 7.80 |
| I-E (%) | 1.88 | 1.02 | 1.4 | 1.36 |
| I-E-NI (%) | 0.03 | 0.04 | 0.05 | 0.04 |
| I-NI (%) | 0.16 | 0.17 | 0.26 | 0.19 |
| I-NI-E (%) | 0.01 | 0.01 | 0.05 | 0.02 |
|
| ||||
| REVASC R. (%) | 4.63 | 3.09 | 4.05 | 3.79 |
| MORT. (%) | 1.38 | 1.45 | 1.61 | 1.48 |
| AVG COST (HUF) | 75,783 | 54,182 | 66,953 | 63,738 |
|
| ||||
| AVG CORR. | 0.38 | 0.12 | 0.37 | N/A |
Percent rate differences of cluster features compared to each other in pairs. For an explanation on features, see Table 3 caption.
| Pathway | Cluster 1 versus cluster 2 | Cluster 1 versus cluster 3 | Cluster 2 versus cluster 3 |
|---|---|---|---|
| E | −1.14% ( | −0.5% ( | +0.65% ( |
| E-NI | −39.58% ( | −32.5% ( | +11.7% ( |
| E-NI-I | −36.64% ( | −28.7% ( | +12.75% ( |
| E-I | +50.17% ( | +15.36% ( | −23.18% ( |
| E-I-NI | −34.2% ( | −51.6% ( | −26.44% ( |
| NI | −50.08% ( | −23.92% ( | +52.43% ( |
| NI-E | −79.93% ( | −66.21% ( | +68.89% ( |
| NI-E-I | −86.13% ( | −70.81% ( | +111.6% ( |
| NI-I | −49.48% ( | −22.91% ( | +52.64% ( |
| NI-I-E | −21.33% ( | −14.47% ( | +8.71% ( |
| I | +70.15% ( | +25.66% ( | −26.14% ( |
| I-E | +83.1% ( | +33.63% ( | −27.01% ( |
| I-E-NI | −21.76% ( | −37.27% ( | −19.72% ( |
| I-NI | −3.38% ( | −37.42% ( | −35.23% ( |
| I-NI-E | −37.93% ( | −89.69% ( | −83.34% ( |
| REVASC R. | +49.39% ( | +14.25% ( | −23.57% ( |
|
| |||
| MORT. | −5.67% ( | −15.25% ( | −10.16% ( |
| AVG COST | +39.86% | +13.18% | −19.07% |
|
| |||
| AVG CORR. | +219.64% | +1.68% | −68.11% |